Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Urban

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Pharmacogenomics|February 27, 2013
Whole-genome sequencing in pharmacogeneticsThomas J Urban
The Mount Sinai Journal of Medicine, New York|March 24, 2010
Race, ethnicity, ancestry, and pharmacogeneticsThomas J Urban
Plos Pathogens|August 13, 2013
Understanding human variation in infectious disease susceptibility through clinical and cellular GWASDennis C Ko, Thomas J Urban
Science Translational Medicine|January 24, 2014
Pharmacogenetics at 50: genomic personalization comes of ageThomas J Urban, David B Goldstein
Inflammatory Bowel Diseases|January 28, 2005
Haplotype structure and ethnic-specific allele frequencies at the OCTN locus: implications for the genetics of Crohn's diseaseThomas J Urban, Kathleen M Giacomini, Neil Risch
Pharmacogenomics|May 19, 2012
Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here?Thomas J Urban, David B Goldstein, Paul B Watkins
Seminars in Liver Disease|June 1, 2014
Genetic basis of drug-induced liver injury: present and futureThomas J Urban, Ann K Daly, Guruprasad P Aithal
Virology|January 12, 2015
Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burdenYi-Fan Lu, David B Goldstein, Thomas J Urban, et al.
Journal of Pharmaceutical Sciences|November 25, 2005
Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variantsTomoe Fujita, Thomas J Urban, Maya K Leabman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 5, 2015
Toward predicting drug-induced liver injury: parallel computational approaches to identify multidrug resistance protein 4 and bile salt export pump inhibitorsMatthew A Welch, Kathleen Köck, Thomas J Urban, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Pharmacogenomics|February 27, 2013
Whole-genome sequencing in pharmacogeneticsThomas J Urban
The Mount Sinai Journal of Medicine, New York|March 24, 2010
Race, ethnicity, ancestry, and pharmacogeneticsThomas J Urban
Plos Pathogens|August 13, 2013
Understanding human variation in infectious disease susceptibility through clinical and cellular GWASDennis C Ko, Thomas J Urban
Science Translational Medicine|January 24, 2014
Pharmacogenetics at 50: genomic personalization comes of ageThomas J Urban, David B Goldstein
Inflammatory Bowel Diseases|January 28, 2005
Haplotype structure and ethnic-specific allele frequencies at the OCTN locus: implications for the genetics of Crohn's diseaseThomas J Urban, Kathleen M Giacomini, Neil Risch
Pharmacogenomics|May 19, 2012
Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here?Thomas J Urban, David B Goldstein, Paul B Watkins
Seminars in Liver Disease|June 1, 2014
Genetic basis of drug-induced liver injury: present and futureThomas J Urban, Ann K Daly, Guruprasad P Aithal
Virology|January 12, 2015
Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burdenYi-Fan Lu, David B Goldstein, Thomas J Urban, et al.
Journal of Pharmaceutical Sciences|November 25, 2005
Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variantsTomoe Fujita, Thomas J Urban, Maya K Leabman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 5, 2015
Toward predicting drug-induced liver injury: parallel computational approaches to identify multidrug resistance protein 4 and bile salt export pump inhibitorsMatthew A Welch, Kathleen Köck, Thomas J Urban, et al.
Pageof 6